These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11356438)

  • 1. Can women in less-developed countries use a simplified medical abortion regimen?
    Elul B; Hajri S; Ngoc NN; Ellertson C; Slama CB; Pearlman E; Winikoff B
    Lancet; 2001 May; 357(9266):1402-5. PubMed ID: 11356438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
    Guengant JP; Bangou J; Elul B; Ellertson C
    Contraception; 1999 Sep; 60(3):167-72. PubMed ID: 10640161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical abortion experiences of married and unmarried women in Tunis, Tunisia.
    Blum J; Hajri S; Chélli H; Mansour FB; Gueddana N; Winikoff B
    Contraception; 2004 Jan; 69(1):63-9. PubMed ID: 14720623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India.
    Coyaji K; Elul B; Krishna U; Otiv S; Ambardekar S; Bopardikar A; Raote V; Ellertson C; Winikoff B
    Contraception; 2002 Jul; 66(1):33-40. PubMed ID: 12169379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
    Warden S; Genkin I; Hum S; Dunn S
    J Obstet Gynaecol Can; 2019 May; 41(5):647-652. PubMed ID: 31007171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
    Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
    Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
    Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
    Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
    Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early medical abortion with self-administered low-dose mifepristone in combination with misoprostol.
    Song LP; Tang SY; Li CL; Zhou LJ; Mo XT
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1705-1711. PubMed ID: 29974571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
    Ferguson I; Scott H
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1532-1542.e2. PubMed ID: 32912726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France.
    Clark WH; Hassoun D; Gemzell-Danielsson K; Fiala C; Winikoff B
    Eur J Contracept Reprod Health Care; 2005 Sep; 10(3):184-91. PubMed ID: 16318966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Dondiuc I; Turcanu S; Winikoff B
    Contraception; 2010 Dec; 82(6):513-9. PubMed ID: 21074013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Chen MJ; Creinin MD
    Obstet Gynecol; 2015 Jul; 126(1):12-21. PubMed ID: 26241251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of unwanted pregnancy in France: modalities and outcomes. The aMaYa study.
    Nisand I; Bettahar K;
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():13-8. PubMed ID: 25462213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial.
    Schreiber CA; Creinin MD; Reeves MF; Harwood BJ
    Contraception; 2006 Dec; 74(6):458-62. PubMed ID: 17157102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.
    Raymond EG; Shannon C; Weaver MA; Winikoff B
    Contraception; 2013 Jan; 87(1):26-37. PubMed ID: 22898359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore.
    Tan YL; Singh K; Tan KH; Gosavi A; Koh D; Abbas D; Winikoff B
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():144-147. PubMed ID: 30179732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.